These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341 [TBL] [Abstract][Full Text] [Related]
25. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. Pan CW; Shen ZJ; Ding GQ J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576 [TBL] [Abstract][Full Text] [Related]
27. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
28. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group]. Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414 [TBL] [Abstract][Full Text] [Related]
29. Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma. Leblanc B; Duclos AJ; Bénard F; Valiquette L; Paquin JM; Lapointe S; Mauffette F; Pharand D; Faucher R; Drouin G; Perreault JP Can J Urol; 2000 Feb; 7(1):944-8. PubMed ID: 11121250 [TBL] [Abstract][Full Text] [Related]
30. Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy. Herr HW Urology; 2007 Jul; 70(1):65-8. PubMed ID: 17656210 [TBL] [Abstract][Full Text] [Related]
31. Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment. Ströck V; Dotevall L; Sandberg T; Gustafsson CK; Holmäng S BJU Int; 2011 May; 107(10):1592-7. PubMed ID: 21166754 [TBL] [Abstract][Full Text] [Related]
32. [Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?]. Yamada Y; Hara I; Kumano M; Furukawa J; Yamanaka K; Kamidono S Hinyokika Kiyo; 2005 Aug; 51(8):539-43. PubMed ID: 16164270 [TBL] [Abstract][Full Text] [Related]
33. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report. Duvnjak P; Laguna M J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190 [TBL] [Abstract][Full Text] [Related]
34. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer]. Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455 [TBL] [Abstract][Full Text] [Related]
35. Prosthetic total knee infection with a bacillus Calmette Guerin (BCG) strain after BCG therapy for bladder cancer. Chazerain P; Desplaces N; Mamoudy P; Leonard P; Ziza JM J Rheumatol; 1993 Dec; 20(12):2171-2. PubMed ID: 8014956 [No Abstract] [Full Text] [Related]
36. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer. Kaneko T; Fujita K; Homma Y Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629 [TBL] [Abstract][Full Text] [Related]
37. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium bovis vertebral osteomyelitis and discitis with adjacent mycotic abdominal aortic aneurysm caused by intravesical BCG therapy: a case report in an elderly gentleman. Samadian S; Phillips FM; Deeab D Age Ageing; 2013 Jan; 42(1):129-31. PubMed ID: 23151379 [TBL] [Abstract][Full Text] [Related]
39. Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group. Koga H; Ozono S; Tsushima T; Tomita K; Horiguchi Y; Usami M; Hirao Y; Akaza H; Naito S; Int J Urol; 2010 Sep; 17(9):759-66. PubMed ID: 20604814 [TBL] [Abstract][Full Text] [Related]
40. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts. Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]